Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials(Journal of Clinical Oncology 2023. DOI: 10.1200/JCO.22.02912 )
あなたは医師ですか。